C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2004
11/25/2004	US20040236112 Hepatitis C Virus (HCV); antiproliferative agents; replication-defective
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040235913 drug abuse; psychological disorders; antidepressants; sexual disorders; hypotensive agents; anxiolytic agernts; Alzheimer's disease; schizophrenia; Parkinson's disease; sleep disorders; reastless leg syndrome; irritable bowel syndrome
11/25/2004	US20040235902 Fluorescent probes for zinc
11/25/2004	US20040235900 Antimicrobial oxazolifinones with improved pharmacokinetic profile and safety advantages
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235892 enzyme inhibitors such as N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea, used for prophylaxis of cancer
11/25/2004	US20040235891 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases
11/25/2004	US20040235824 For the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235821 Novel compounds
11/25/2004	US20040235819 5-alkylaminocarbonyl-substituted, e.g., 4-(1-benzyl-piperidin-4-yl)-2-isopropyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepine-5-carboxylic acid tert-butylamide; gamma -secretase inhibitors for the treatment of Alzheimer's disease.
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040234814 Blue light-emitting compounds, blue light-emitting polymers, processes of preparing the blue light-emitting compounds and luminescent element including the blue light-emitting polymers
11/25/2004	DE10320782A1 Substituierte Oxyarene Substituted Oxyarene
11/25/2004	DE10308351A1 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as medicaments
11/25/2004	CA2528220A1 Indazole-derivatives as factor xa inhibitors
11/25/2004	CA2526086A1 Heterocyclic compounds
11/25/2004	CA2526066A1 New indole derivatives as factor xa inhibitors
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/25/2004	CA2525849A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2524958A1 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	CA2524470A1 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004	CA2524434A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	CA2523431A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/24/2004	EP1479679A1 Triazole-derivatives as factor Xa inhibitors
11/24/2004	EP1479678A1 Pyrazole-derivatives as factor xa inhibitors
11/24/2004	EP1479677A1 New indole derivatives as factor xa inhibitors
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479675A1 Indazole-derivatives as factor Xa inhibitors
11/24/2004	EP1479674A1 Imidiazole-derivatives as factor xa inhibitors
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1478644A1 Substituted 4-pyrazolyl pyrazolines used for pest control
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478634A1 Furanone derivatives
11/24/2004	EP1478632A1 Substituted aryl alkenoic acid heterocyclic amides possessing pungent taste
11/24/2004	EP1478630A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or -oxazoles
11/24/2004	EP1478629A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
11/24/2004	EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004	EP1478625A1 Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478437A1 Acc inhibitors
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	CN1549818A Isoxazoline derivatives as P, N ligands
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549813A Pyrimidineamines as angiogenesis modulators
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004	CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/23/2004	US6821994 A peroxisome proliferator activated receptor regulator, an oxazol-4-yl-methylfuran-2-yl-2-propenylthio- or sulfonyl- or sulfinyl-acetic acid or methyl ester
11/23/2004	US6821992 Fungicides
11/23/2004	US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004	US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004	US6821977 Antidiabetic agents
11/23/2004	US6821972 3-heterocyclylpropanohydroxamic acid PCP inhibitors
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/18/2004	WO2004099200A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
11/18/2004	WO2004099199A1 Oxazolidinone derivatives as antimicrobials
11/18/2004	WO2004099198A1 Benzoxazinone derivatives having affinity for 5- ht receptors, their preparation and use
11/18/2004	WO2004099197A2 Substituted oxyarenes, and use thereof for controlling pests
11/18/2004	WO2004099196A1 Benzoxazinone derivatives, their preparation and use
11/18/2004	WO2004099195A1 3-carbonylaminothiophenes and their use as fungicides
11/18/2004	WO2004099178A1 Chemical compounds
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099164A1 Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
11/18/2004	WO2004099156A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004098610A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004	WO2004098609A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098528A2 Pyrazole-amine compounds useful as kinase inhibitors
11/18/2004	WO2004098518A2 Pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004098498A2 Indole acetic acid derivatives and their use as pharmaceutical agents
11/18/2004	WO2004043954A3 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229917 Imidazole derivatives
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229893 Substituted benzothiazole amide derivatives
11/18/2004	US20040229892 HIV integrase inhibitors
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229876 Quinoline derivatives and quinazoline derivatives having azolyl group
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229868 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229861 CGRP receptor antagonists

1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 647